Data On VIVUS' Qnexa To Be Presented At European Congress Focused On Cardiovascular Prevention And Rehabilitation

VIVUS, Inc. (Nasdaq: VVUS) announced that new data on Qnexa®, an investigational drug candidate, will be presented at EuroPRevent 2010, the annual congress of the European Association for Cardiovascular Prevention and Rehabilitation, organized by the European Society of Cardiology, in Prague, Czech Republic...
Tags:
Syndicate content

 

Featured Video